Manickam Rangaraju
Corporate Officer/Principal at AiCuris GmbH & Co. KG
Profile
Manickam Rangaraju is currently the Head-Development at AiCuris GmbH & Co. KG since 2015.
Prior to this, he worked as a Clinical Development professional at Hoechst Marion Roussel SA, Aventis SA, and Roussel Uclaf SA. He also served as the Chief Technology Officer at Novexel SA.
Manickam Rangaraju active positions
| Companies | Position | Start |
|---|---|---|
AiCuris GmbH & Co. KG
 AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Corporate Officer/Principal | 2015-04-30 |
Former positions of Manickam Rangaraju
| Companies | Position | End |
|---|---|---|
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Corporate Officer/Principal | - |
| Roussel Uclaf SA | Corporate Officer/Principal | - |
| Hoechst Marion Roussel SA | Corporate Officer/Principal | - |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
| Roussel Uclaf SA | Health Technology |
| Hoechst Marion Roussel SA | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Commercial Services |
- Stock Market
- Insiders
- Manickam Rangaraju
